Trigg Leslie 4

What Happened

• Trigg Leslie, Chair and CEO of Outset Medical (OM), received a grant of 99,160 restricted stock units (RSUs) on June 26, 2026. The RSUs were granted at $0.00 (no cash purchase) and each RSU represents a contingent right to one share of common stock. This was an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: June 26, 2026; Filing date: June 29, 2026 (filed timely within SEC Form 4 deadlines).
• Amount: 99,160 RSUs granted; acquisition price reported as $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote (vesting terms): 33.33% vests on June 26, 2027; the remaining 66.67% vests in equal installments over the following two years on Feb 15, May 15, Aug 15, and Nov 15 (vesting subject to continuous service).
• Transaction type: Award/Grant (A); no immediate sale or cashless exercise reported.

Context

• RSU grants are a form of compensation and vest over time; they do not represent an immediate market purchase or sale. Because vesting is time- and service-based, these awards are typically intended for retention and alignment with company performance rather than signaling a short-term trading view.